Skip to main content
Fig. 3 | Lipids in Health and Disease

Fig. 3

From: Polar lipids modify Alzheimer’s Disease pathology by reducing astrocyte pro-inflammatory signaling through platelet-activating factor receptor (PTAFR) modulation

Fig. 3

A Western blotting reveals an increase of PTAFR on protein level after exposure to Aβ that is normalized by treatment with SPL and YPL (one-way ANOVA, p<0.0001; Tukey post hoc test: Ctrl vs. Aβ p<0.0001; Aβ vs. Aβ+SPL p<0.001; Aβ vs. Aβ+YPL p<0.001, n=3-5). B Western blotting shows no effect of SPL and YPL alone on PTAFR levels (one-way ANOVA, p=0.471, n=3-5). B, C Tubulin was used as a housekeeping protein for normalization

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X